Opioid Epidemic

Background on the Opioid Epidemic

Scope of the Problem:

Starting in the late 1990s, aggressive promotion by painkller manufacturers caused U.S. opioid prescribing to nearly quadruple in a decade, addicting millions of Americans. The only other nation to increase opioid prescribing this much is Canada, which is also experiencing an epidemic of opioid addiction and overdose.

A class of extremely potent, synthetic opioids known as fentanyls began infiltrating the illicit opioid supply in multiple regions of the U.S. and Canada about a decade ago, accelerating opioid-related deaths even further. They now dominate the illicit opioid supply across both countries and are also increasingly present in non-opioid drugs (e.g., cocaine).

The U.S. has reduced opioid prescribing over the past 15 years, but still has a higher per capita rate than any other nation. 

Licit and illicit opioids cause nearly 200 fatal overdoses in the U.S. per day.

The epidemic of opioid addiction and overdose has damaged public health in the U.S. more than the HIV/AIDS epidemic, and is estimated to cost the nation at least a trillion dollars a year.
 

Challenges in Policy and Practice:

Blanket anti-opioid policies deprive patients who need opioids of their medication, causing further suffering.

Incarcerating opioid addicted individuals causes them to lose tolerance for the drug, making their normal dose potentially fatal upon their release from jail or prison.

The most effective medications for treatment of opioid addiction and for rescue during overdose are not universally available.

Non-opioid alternatives for pain are underutilized.